Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$1.57 CAD
Change Today 0.00 / 0.00%
Volume 38.9K
As of 3:46 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

titan medical inc (TMD) Snapshot

Open
C$1.59
Previous Close
C$1.57
Day High
C$1.62
Day Low
C$1.56
52 Week High
06/30/14 - C$2.74
52 Week Low
11/18/14 - C$1.12
Market Cap
161.0M
Average Volume 10 Days
64.8K
EPS TTM
C$-0.14
Shares Outstanding
102.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TITAN MEDICAL INC (TMD)

Related News

No related news articles were found.

titan medical inc (TMD) Related Businessweek News

No Related Businessweek News Found

titan medical inc (TMD) Details

Titan Medical Inc., a development stage company, focuses on design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing Single Port Orifice Robotic Technology (SPORT) Surgical System, a single-port/single-incision robotic surgical system that comprises a surgeon-controlled robotic platform, which includes a 3D vision system and interactive instruments for performing MIS procedures. Its SPORT Surgical System also includes a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures. The SPORT Surgical System is being designed to expand robotic surgery into simple and complex areas of surgical specialties that are under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces for general abdominal, gynecologic, and urologic indications. The company has in-licensing relationships with Live Data, Inc., for its LiveData RTI Server technology; the Mayo Foundation for medical education and research for a surgical stapler delivery system; and Columbia University for a single-port robotic surgical system for use in single-port surgery. Titan Medical Inc. is headquartered in Toronto, Canada.

titan medical inc (TMD) Top Compensated Officers

Chairman, Chief Executive Officer and Member ...
Total Annual Compensation: C$167.0K
President and Director
Total Annual Compensation: C$236.9K
Chief Financial Officer and Secretary
Total Annual Compensation: C$156.8K
Compensation as of Fiscal Year 2013.

titan medical inc (TMD) Key Developments

Titan Medical Inc. Signs Agreement with Worldwide Supplier of Single Patient Use Robotic Tools

Titan Medical Inc. announced that it has signed an agreement with a worldwide supplier of endomechanical devices for the development and supply of single patient use robotic tools. Under the terms of the agreement, the supplier will create customized single patient use tools for Titan's SPORTTM Surgical System.

Titan Medical Inc. Adopts Amendment to By-Laws Requiring Advance Notice of Nomination of Directors

Titan Medical Inc. announced that it has adopted an amendment to its by-laws, similar to by-law amendments and policies recently adopted by a number of other Canadian public companies, requiring advance notice to the Company for nominations of directors by shareholders other than through a requisitioned meeting or shareholder proposal pursuant to applicable corporate laws. The by-law amendment is not intended to discourage director nominations. Rather it is intended to facilitate orderly and efficient meetings at which directors are to be elected and to permit shareholders to exercise their voting rights in an informed manner by allowing them to receive sufficient information with respect to all director nominees and reasonable time for appropriate consideration. The by-law amendment provides shareholders, directors and management of the Company with a clear framework for nominating directors in an orderly and fair manner. The by-law amendment fixes a deadline by which holders of record of common shares of the Company must submit director nominations to the Company prior to any annual or special meeting of shareholders and sets the information that a shareholder must include in the notice to the Company for the notice to be in proper written form in order for any director nominee to be eligible for election at any annual or special meeting of shareholders. In the case of an annual meeting of shareholders, notice to the Company must be made not less than 30 nor more than 65 days prior to the date of the annual meeting; provided, however, that in the event that the annual meeting is to be held on a date that is less than 40 days after the date on which the first public announcement of the date of the annual meeting was made, notice may be made not later than the close of business on the 10th day following such public announcement. In the case of a special meeting of shareholders (which is not also an annual meeting), notice to the Company must be made not later than the close of business on the 15th day following the day on which the first public announcement of the date of the special meeting was made. The by-law amendment is effective from March 20, 2015 and will be presented for confirmation by shareholders at the Company's next annual shareholders meeting to be held in 2015.

Titan Medical Inc. Completes the Next Step in the Development of the SPORTTM Surgical System

Titan Medical Inc. completed the next step in the development of the SPORTTM Surgical System - the design and test of a feasibility prototype. It demonstrates feasibility to build a next generation workstation and advanced instruments, and it enables expanded use of the SPORT Surgical System.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMD:CN C$1.57 CAD 0.00

TMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMD.
View Industry Companies
 

Industry Analysis

TMD

Industry Average

Valuation TMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TITAN MEDICAL INC, please visit www.titanmedicalinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.